Clinical trials often face low accrual and retention, and involving communities in their planning and conduct is crucial to ...

A new campaign at UCC aims to make health research more inclusive, to include under-served groups like women, ethnic ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

A new publication by two University of Cincinnati researchers contends that adjusting how researchers approach their statistical analysis has the potential to change the lives of children and ...

The annual review of clinical trials for Alzheimer’s highlights a growing number of active trials and drugs that could help ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

UofL Health – Brown Cancer Center recently became the first facility in the United States of America to offer its patients ...

As more and more people receive medicinal cannabis prescriptions, we’re left with a system that is misaligned with its ...

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

Progress towards The Lancet Commission on Global Surgery's 2030 targets has been too slow and too patchy, particularly in low ...